Astellas Pharma, Inc.
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products mainly target therapeutic fields such as transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. Its global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.